TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia
Status:
Not yet recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
To evaluate the effect of dexmedetomidine as an adjuvant of ropivacaine in the TAP block on
cesarean section parturients under multimodal analgesia, optimize the multimodal analgesia
program for cesarean section, and guide perioperative analgesia managemen。This is a single
center, double-blind, randomized clinical trial.